Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
IMRX Quote, Financials, Valuation and Earnings
Last price:
$4.31
Seasonality move
:
56.22%
Day range:
$3.82 - $4.17
52-week range:
$1.00 - $4.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
393.82x
P/B ratio:
3.41x
Volume:
637.7K
Avg. volume:
2.3M
1-year change:
216.8%
Market cap:
$142.5M
Revenue:
--
EPS (TTM):
-$1.96
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3M | $2.1M | $317K | -- | -- | |
| Revenue Growth (YoY) | 20.41% | -10.02% | -84.76% | -- | -- | |
| Cost of Revenues | $1.3M | $1.2M | $158.1K | -- | -- | |
| Gross Profit | $1M | $926.9K | $158.8K | -- | -- | |
| Gross Profit Margin | 44.61% | 44.56% | 50.11% | -- | -- | |
| R&D Expenses | $15M | $26.5M | $36.3M | $41.6M | $48M | |
| Selling, General & Admin | $3.1M | $8.3M | $15.6M | $16.8M | $16.1M | |
| Other Inc / (Exp) | -- | -$127.1K | $216.8K | $1.3M | $441.5K | |
| Operating Expenses | $18.1M | $34.8M | $51.9M | $58.4M | $64.1M | |
| Operating Income | -$17.1M | -$33.9M | -$51.7M | -$58.4M | -$64.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$17M | -$33.8M | -$50.5M | -$53.5M | -$61M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$307.5K | -- | -- | -- | |
| Net Income to Company | -$17M | -$33.5M | -$50.5M | -$53.5M | -$61M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$17M | -$33.5M | -$50.5M | -$53.5M | -$61M | |
| Basic EPS (Cont. Ops) | -$1.26 | -$2.46 | -$1.91 | -$1.88 | -$2.04 | |
| Diluted EPS (Cont. Ops) | -$1.26 | -$2.46 | -$1.91 | -$1.88 | -$2.04 | |
| Weighted Average Basic Share | $13.5M | $13.6M | $26.4M | $28.4M | $30M | |
| Weighted Average Diluted Share | $13.5M | $13.6M | $26.4M | $28.4M | $30M | |
| EBITDA | -$17M | -$33.7M | -$51.5M | -$58.1M | -$63.7M | |
| EBIT | -$17.1M | -$33.9M | -$51.7M | -$58.4M | -$64.1M | |
| Revenue (Reported) | $2.3M | $2.1M | $317K | -- | -- | |
| Operating Income (Reported) | -$17.1M | -$33.9M | -$51.7M | -$58.4M | -$64.1M | |
| Operating Income (Adjusted) | -$17.1M | -$33.9M | -$51.7M | -$58.4M | -$64.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $748.2K | $183.7K | -- | -- | -- | |
| Revenue Growth (YoY) | 54.89% | -75.45% | -- | -- | -- | |
| Cost of Revenues | $409.2K | $90.9K | -- | -- | -- | |
| Gross Profit | $339K | $92.9K | -- | -- | -- | |
| Gross Profit Margin | 45.31% | 50.55% | -- | -- | -- | |
| R&D Expenses | $5.4M | $9.1M | $10.2M | $11.2M | $11.5M | |
| Selling, General & Admin | $1.2M | $4M | $4.4M | $4.1M | $4M | |
| Other Inc / (Exp) | -- | -$103.2K | $244.1K | $213K | -- | |
| Operating Expenses | $6.6M | $13M | $14.6M | $15.3M | $15.5M | |
| Operating Income | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.2M | -$12.9M | -$13.5M | -$14.3M | -$15M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.49 | -$0.51 | -$0.49 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.49 | -$0.51 | -$0.49 | -$0.42 | |
| Weighted Average Basic Share | $13.5M | $26.4M | $26.4M | $29.4M | $35.5M | |
| Weighted Average Diluted Share | $13.5M | $26.4M | $26.4M | $29.4M | $35.5M | |
| EBITDA | -$6.2M | -$12.7M | -$14.5M | -$15.2M | -$15.4M | |
| EBIT | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Revenue (Reported) | $748.2K | $183.7K | -- | -- | -- | |
| Operating Income (Reported) | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Operating Income (Adjusted) | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6M | $1.5M | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4M | $834.8K | -- | -- | -- | |
| Gross Profit | $1.1M | $680.7K | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $17.6M | $30.2M | $37.4M | $42.6M | $48.2M | |
| Selling, General & Admin | $3.7M | $11M | $16M | $16.4M | $16M | |
| Other Inc / (Exp) | -- | -$230.3K | $564.2K | $1.3M | $228.5K | |
| Operating Expenses | $21.2M | $41.3M | $53.5M | $59.1M | $64.2M | |
| Operating Income | -$20.1M | -$40.6M | -$53.4M | -$59.1M | -$64.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$20.1M | -$40.5M | -$51.1M | -$54.2M | -$61.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$20.1M | -$40.2M | -$51.2M | -$54.2M | -$61.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$20.1M | -$40.2M | -$51.2M | -$54.2M | -$61.8M | |
| Basic EPS (Cont. Ops) | -$1.49 | -$1.71 | -$1.94 | -$1.87 | -$1.96 | |
| Diluted EPS (Cont. Ops) | -$1.49 | -$1.71 | -$1.94 | -$1.87 | -$1.96 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$20M | -$40.3M | -$53.2M | -$58.7M | -$63.9M | |
| EBIT | -$20.1M | -$40.6M | -$53.4M | -$59.1M | -$64.2M | |
| Revenue (Reported) | $2.6M | $1.5M | -- | -- | -- | |
| Operating Income (Reported) | -$20.1M | -$40.6M | -$53.4M | -$59.1M | -$64.2M | |
| Operating Income (Adjusted) | -$20.1M | -$40.6M | -$53.4M | -$59.1M | -$64.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $748.2K | $183.7K | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $409.2K | $90.9K | -- | -- | -- | |
| Gross Profit | $339K | $92.9K | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $5.4M | $9.1M | $10.2M | $11.2M | $11.5M | |
| Selling, General & Admin | $1.2M | $4M | $4.4M | $4.1M | $4M | |
| Other Inc / (Exp) | -- | -$103.2K | $244.1K | $213K | -- | |
| Operating Expenses | $6.6M | $13M | $14.6M | $15.3M | $15.5M | |
| Operating Income | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.2M | -$12.9M | -$13.5M | -$14.3M | -$15M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.49 | -$0.51 | -$0.49 | -$0.42 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.49 | -$0.51 | -$0.49 | -$0.42 | |
| Weighted Average Basic Share | $13.5M | $26.4M | $26.4M | $29.4M | $35.5M | |
| Weighted Average Diluted Share | $13.5M | $26.4M | $26.4M | $29.4M | $35.5M | |
| EBITDA | -$6.2M | -$12.7M | -$14.5M | -$15.2M | -$15.4M | |
| EBIT | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Revenue (Reported) | $748.2K | $183.7K | -- | -- | -- | |
| Operating Income (Reported) | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Operating Income (Adjusted) | -$6.2M | -$12.9M | -$14.6M | -$15.3M | -$15.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $37.1M | $74.9M | $72.6M | $59.4M | $36.1M | |
| Short Term Investments | -- | $74.3M | $32.9M | $26.3M | -- | |
| Accounts Receivable, Net | $500.1K | $246K | $12.4K | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $141K | $2.9M | $3.2M | $3.4M | $3.4M | |
| Total Current Assets | $37.7M | $152.3M | $108.7M | $89.1M | $39.6M | |
| Property Plant And Equipment | $677.5K | $6.1M | $5.8M | $5.4M | $4.8M | |
| Long-Term Investments | -- | $996.6K | -- | -- | -- | |
| Goodwill | -- | $6.7M | $6.7M | $6.7M | $6.7M | |
| Other Intangibles | -- | $439K | $409K | $379.7K | $350.4K | |
| Other Long-Term Assets | $14.3K | $102.1K | $743.7K | $1M | $1.3M | |
| Total Assets | $38.4M | $166.7M | $122.4M | $102.6M | $52.7M | |
| Accounts Payable | $1.5M | $1.4M | $3.2M | $2.1M | $2M | |
| Accrued Expenses | $535.3K | $1M | $869.9K | $1.5M | $1.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $76.3K | $274K | $378.7K | $300.1K | $338.4K | |
| Other Current Liabilities | -- | -- | $19.8K | $259.8K | $233.7K | |
| Total Current Liabilities | $2.3M | $5.6M | $8.1M | $7.8M | $7.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $60.9M | $10.7M | $12.5M | $12M | $11.3M | |
| Common Stock | $5K | $26.3K | $26.4K | $29.3K | $31.1K | |
| Other Common Equity Adj | -- | -$49K | -$30.1K | -$780 | -- | |
| Common Equity | -$22.5M | $156M | $109.9M | $90.6M | $41.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$22.5M | $156M | $109.9M | $90.6M | $41.4M | |
| Total Liabilities and Equity | $38.4M | $166.7M | $122.4M | $102.6M | $52.7M | |
| Cash and Short Terms | $37.1M | $149.2M | $105.5M | $85.7M | $36.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $30.9M | $75.2M | $77.4M | $66.3M | $35.9M | |
| Short Term Investments | -- | $62.6M | $14.1M | $5M | -- | |
| Accounts Receivable, Net | $492.4K | $279.6K | $1.1K | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $756.6K | $1.5M | $2.7M | $3.2M | $2.3M | |
| Total Current Assets | $32.2M | $139.5M | $94.2M | $74.4M | $38.2M | |
| Property Plant And Equipment | $660.1K | $5.7M | $5.6M | $5.3M | $4.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $6.7M | $6.7M | $6.7M | $6.7M | |
| Other Intangibles | -- | $430.9K | $401.6K | $372.4K | $343.1K | |
| Other Long-Term Assets | $14.3K | $89.6K | $743.7K | $1.2M | $810.9K | |
| Total Assets | $32.9M | $152.4M | $107.7M | $88M | $50.7M | |
| Accounts Payable | $1.4M | $1.6M | $2.7M | $2.3M | $1.3M | |
| Accrued Expenses | $491.6K | $833.2K | $907K | $1.5M | $2.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $78.5K | $265.4K | $363.2K | $298.5K | $352.5K | |
| Other Current Liabilities | -- | $47.2K | $26.3K | $23.6K | $56.5K | |
| Total Current Liabilities | $2.8M | $3.7M | $5.5M | $5.2M | $5.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.3M | $8.4M | $9.9M | $9.3M | $8.8M | |
| Common Stock | $13.5K | $26.4K | $26.5K | $29.7K | $36K | |
| Other Common Equity Adj | -- | -$167.4K | $510 | -$1.1K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $29.6M | $144.1M | $97.8M | $78.7M | $41.8M | |
| Total Liabilities and Equity | $32.9M | $152.4M | $107.7M | $88M | $50.7M | |
| Cash and Short Terms | $30.9M | $137.8M | $91.5M | $71.3M | $35.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17M | -$33.5M | -$50.5M | -$53.5M | -$61M | |
| Depreciation & Amoritzation | $79.3K | $159.1K | $277.3K | $352.1K | $385.1K | |
| Stock-Based Compensation | $1.1M | $1.8M | $4.1M | $5.7M | $6.5M | |
| Change in Accounts Receivable | -$290.2K | $279.7K | $233.6K | $12.4K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$14.6M | -$30.9M | -$44.1M | -$49M | -$55M | |
| Capital Expenditures | $53.4K | $60.8K | $742.5K | -- | -- | |
| Cash Acquisitions | -- | $70.4K | -- | -- | -- | |
| Cash From Investing | -$53.4K | -$75.6M | $41.8M | $7.3M | $26.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2.1M | -$281.4K | -$203.8K | -$41K | |
| Cash From Financing | $38M | $144.3M | $19K | $28.4M | $5.3M | |
| Beginning Cash (CF) | $13.8M | $37.1M | $74.9M | $72.6M | $59.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $23.3M | $37.8M | -$2.3M | -$13.2M | -$23.3M | |
| Ending Cash (CF) | $37.1M | $74.9M | $72.6M | $59.4M | $36.1M | |
| Levered Free Cash Flow | -$14.7M | -$30.9M | -$44.8M | -$49.3M | -$55.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Depreciation & Amoritzation | $33.9K | $200.6K | $83.8K | $97.5K | $92.6K | |
| Stock-Based Compensation | $182.2K | $897.7K | $1.3M | $1.5M | $1.7M | |
| Change in Accounts Receivable | $7.7K | -$33.6K | $11.4K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.1M | -$12.3M | -$14.4M | -$15.5M | -$14.1M | |
| Capital Expenditures | $16.6K | $115K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.6K | $12.4M | $19M | $21.4M | -$9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $193.1K | $239.4K | $979.9K | $13.8M | |
| Beginning Cash (CF) | $37.1M | $74.9M | $72.6M | $59.4M | $36.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.2M | $316.9K | $4.8M | $6.9M | -$279K | |
| Ending Cash (CF) | $30.9M | $75.2M | $77.4M | $66.3M | $35.9M | |
| Levered Free Cash Flow | -$6.2M | -$12.4M | -$14.4M | -$15.5M | -$14.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$20.1M | -$40.2M | -$51.2M | -$54.2M | -$61.8M | |
| Depreciation & Amoritzation | $98K | $325.8K | $160.5K | $365.8K | $380.1K | |
| Stock-Based Compensation | $996.9K | $2.5M | $4.4M | $5.9M | $6.7M | |
| Change in Accounts Receivable | -$143.5K | $238.4K | $278.6K | $1K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$18.4M | -$37M | -$46.2M | -$50M | -$53.6M | |
| Capital Expenditures | $65.6K | $159.3K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$65.6K | -$63.2M | $48.4M | $9.7M | $5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $37M | $144.5M | $65.3K | $29.2M | $18.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18.5M | $44.3M | $2.2M | -$11.1M | -$30.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$18.5M | -$37.2M | -$46.9M | -$50.4M | -$53.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.2M | -$12.9M | -$13.6M | -$14.3M | -$15M | |
| Depreciation & Amoritzation | $33.9K | $200.6K | $83.8K | $97.5K | $92.6K | |
| Stock-Based Compensation | $182.2K | $897.7K | $1.3M | $1.5M | $1.7M | |
| Change in Accounts Receivable | $7.7K | -$33.6K | $11.4K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.1M | -$12.3M | -$14.4M | -$15.5M | -$14.1M | |
| Capital Expenditures | $16.6K | $115K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16.6K | $12.4M | $19M | $21.4M | -$9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $193.1K | $239.4K | $979.9K | $13.8M | |
| Beginning Cash (CF) | $37.1M | $74.9M | $72.6M | $59.4M | $36.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.2M | $316.9K | $4.8M | $6.9M | -$279K | |
| Ending Cash (CF) | $30.9M | $75.2M | $77.4M | $66.3M | $35.9M | |
| Levered Free Cash Flow | -$6.2M | -$12.4M | -$14.4M | -$15.5M | -$14.1M | |
Get IMRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IMRX
Sector
P/E ratio
--
23.88x
PEG ratio
-0.15x
0.00x
P/B ratio
3.41x
1.80x
Price / LTM sales
393.82x
1.65x
Growth Metrics
IMRX
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$0.42
-$0.20
Profitability
IMRX
Sector
Profitability FY 2023
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
5
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
4
Balance Sheet
IMRX
Sector
Total cash
$35.9M
$35.5M
Short term investments
--
$29.7M
Total assets
$52.7M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
